Archer Daniels Midland Interest Paid remained flat by 0.0% to $157.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 11.4%, from $177.50M to $157.25M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 22.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $276.00M | $409.00M | $711.00M | $710.00M | $629.00M |
| YoY Change | — | +48.2% | +73.8% | -0.1% | -11.4% |